SECOND SIGHT MEDICAL PRODUCTS INC
Profile
Company Names
SECOND SIGHT MEDICAL PRODUCTS INC
Addresses
13170 TELFAIR AVENUE, SYLMAR, CA 91342
12744 SAN FERNANDO ROAD SUITE 400, SYLMAR, CA 91342
12744 SAN FERNANDO ROAD, SUITE 400, SYLMAR, CA 91342
12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR, CA 91342
Phone Numbers
818-833-5000
Entity Type:
CORPORATION
Industry:
OTHER HEALTH CARE, BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
CALIFORNIA
Total Amount Raised:
$85,797,709.00
Number of Funding Rounds:
14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2021-03-26
$27,900,000.00
$27,900,000.00
$0.00
Equity
13
2018-12-12
$2,999,991.00
$2,999,991.00
$0.00
Equity
12
2018-10-18
$3,997,718.00
$3,997,718.00
$0.00
Equity
11
2018-08-14
$5,000,000.00
$5,000,000.00
$0.00
Equity
10
2018-05-03
$10,000,000.00
$10,000,000.00
$0.00
Equity
9
2013-09-28
$11,000,000.00
$12,000,000.00
$1,000,000.00
Equity
8
2013-08-15
$6,000,000.00
$10,500,000.00
$4,500,000.00
Equity
7
2012-02-15
$2,000,000.00
$2,000,000.00
$0.00
Equity
6
2011-12-15
$2,000,000.00
$2,000,000.00
$0.00
Equity
5
2011-03-15
$3,000,000.00
$6,300,000.00
$3,300,000.00
4
2010-12-21
$1,900,000.00
$3,800,000.00
$1,900,000.00
3
2010-11-15
$3,500,000.00
$3,500,000.00
$0.00
2
2010-08-27
$1,500,000.00
$3,000,000.00
$1,500,000.00
1
2009-11-25
$5,000,000.00
$5,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
TOM
FOGARTY
DIRECTOR
ROBERT
GREENBERG
EXECUTIVE OFFICER, DIRECTOR
WILLIAM
LINK
DIRECTOR
NEOVISTA INC
| LENSX LASERS INC
| DOSE MEDICAL CORP
| SECOND SIGHT MEDICAL PRODUCTS INC
| OCULEVE, INC.
| VERSANT VENTURE CAPITAL V, L.P.
| VERSANT AFFILIATES FUND V, L.P.
| VERSANT OPHTHALMIC AFFILIATES I, L.P.
| VERSANT VENTURE CAPITAL V (CANADA), LP
| ALPHAEON CORP
| ONEFOCUS VISION, INC.
| PRELUDE CORP
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| SIGHTLIFE SURGICAL, INC.
| RXSIGHT, INC.
| TEARCLEAR CORP.
| EYEBRAIN MEDICAL, INC.
| CORNEAGEN INC.
| ALLEGRO OPHTHALMICS, LLC
| VIALASE, INC.
| EQUINOX OPHTHALMIC, INC.
| NEUROLENS, INC.
JONATHAN
WILL
MCGUIRE
EXECUTIVE OFFICER, DIRECTOR
AARON
MENDELSOHN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845]
NO REVENUES
Equity
2021-03-26
D
BIOTECHNOLOGY
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845]
$5,000,001 - $25,000,000
Equity
2018-12-12
D
BIOTECHNOLOGY
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845]
$5,000,001 - $25,000,000
Equity
2018-10-18
D
BIOTECHNOLOGY
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845]
$5,000,001 - $25,000,000
Equity
2018-08-14
D
BIOTECHNOLOGY
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845]
$5,000,001 - $25,000,000
Equity
2018-05-03
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

